series-a
Stage
1
Investors
About
Santero is a spin-off from the Université libre de Bruxelles developing first-in-class antibiotic therapies to treat multi-drug resistant infections and address antimicrobial resistance.
Explore Santero's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.